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1. Introduction
Pulmonary trunk banding is a technique of palliative surgical therapy. It has been used as a
staged approach to operative correction for children born with cardiac defects characterized
by left-to-right shunting or in need for ventricle retraining. This technique can be used to
somehow diminish pulmonary overcirculation or to promote myocardial hypertrophy until
subsequent total repair be possible. It consists of placing a band well proximal to the pulmo‐
nary artery (PA) bifurcation. The band is tightened and secured by suture to narrow the main
PA, until the pressure distal to the band is one-third to one-half that of the aorta. Excessive
blood flow to the lungs is therefore diminished by constricting the PA circumference, thereby
achieving the desired limitation of the pulmonary flow and a balance with aortic blood flow.
Nevertheless, skill and accuracy of the surgery, supplemented by good fortune are most likely
to assure success in this imprecise conventional procedure. In addition, the band commonly
used is fixed and unchanged in the postoperative course. It means that adjustment of the
traditional band is unpredictable and empiric, performed under artificial conditions, different
from the postoperative period. Since mid-80’s, early definitive intracardiac repair has largely
replaced palliation with PA banding. This trend has evolved because many centers have
demonstrated improved outcomes with primary corrective surgery as an initial intervention
in the neonate with congenital heart disease. Although the use of PA banding has recently
decreased significantly, it continues to maintain a therapeutic role in certain subsets of patients
with congenital heart disease. PA banding may be applicable to the very sick and small infants
with torrential pulmonary blood flow, commonly producing heart failure beyond age one to
two months, when diminished pulmonary vascular resistance allows substantial left-to-right
shunting. Babies usually have feeding difficulties and failure to gain weight and grow.
Multiple muscular ventricular septal defects with a "Swiss cheese" septum, single or multiple
ventricular septal defects with coarctation of the aorta or interrupted aortic arch, single
ventricle type of defects with increased pulmonary blood flow, are among the lesions in which
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the use of PA banding may allow time for recovery until the patient can be submitted to
definitive surgery.
PA banding has also played a role in the preparation and “training” of the left ventricle (LV)
in patients with d-transposition of the great arteries (TGA) that are evaluated for a delayed
arterial switch procedure (Jatene procedure). It has also been applied in patients with congen‐
itally corrected TGA (CCTGA) or after Senning or Mustard operations with right ventricular
(RV) failure. It is now recognized that the arterial switch operation can be done only with a
LV conditioned to pump against systemic resistance. After birth, the LV starts pumping blood
against the progressive low-resistance pulmonary vasculature, while the RV assumes the
systemic function, and also the necessary muscle mass, to overcome a higher vascular
resistance. These significant differences in LV and RV muscle mass progress over time and
may assume considerable importance if the LV is suddenly required to perform against
systemic vascular resistance, as in the arterial switch operation. For the majority of the patients
with TGA referred beyond the neonatal period, who presents with an intact (or virtually intact)
ventricular septum, the LV cannot retain pressure close to systemic levels. It is important to
take advantage of these anatomic features during the neonatal period, in which LV is still
adequate to handle systemic circulation, to carry out the arterial switch operation in a “safe”
period. A number of circumstances can arise, causing postponement of surgery beyond the
neonatal period. For example, a neonate may be seriously ill with necrotizing enterocolitis,
renal or hepatic failure, or a hemorrhage in the central nervous system. Also, the neonate may
be geographically distant from a center offering the arterial switch operation.
The establishment of the arterial switch operation as the best option for the surgical treatment
of TGA, as well as the well-studied concept about the RV’s inability to maintain appropriate
performance as a long-term systemic ventricle in atrial inversion operations or in CTTGA, led
many centers to retrain the hypotrophied LV, aiming to surgically recruit it for systemic
circulation. Therefore, arterial switch operation must be performed after preliminary PA
banding, with or without a systemic to PA shunt, to stimulate the development of LV muscle
mass, followed by an arterial switch operation later on, a concept introduced by Yacoub et al.
in 1977. The retraining period between the two stages will allow the LV to function as a systemic
pump. Some years later, the Boston Children’s Hospital group introduced the concept of rapid,
two-stage arterial switch operation for TGA, limiting the interval between the first and the
second operation to an average of seven days. However, one of the greatest limitations of this
technical approach was related to the lack of adjustability of the PA banding. The degree of
PA banding may be inadequate or imprecise and can cause an important acute systolic
overload of the LV. That trial succeeded in their objective, once there was significant cardiac
mass acquisition in about 7 days, reducing the risks of complications resulted from the primary
repair of TGA in a patient with unprepared LV. However, the “rapid approach” produced
some degree of unsatisfactory myocardial contractile performance in the late follow-up of
about one fourth of the patients. In addition, other centers have reported a high morbidity and
mortality rates associated to that 2-stage approach. Experimental studies have demonstrated
myocardial edema and necrosis in hearts that experience abrupt systolic overload, followed
by late ventricular failure. That is why the use of an adjustable PA banding system for LV
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retraining to this subset of patients became of interest to many investigators. Since then, several
studies have been carried out to achieve the most physiologic way to obtain LV retraining.
In developing countries, the number of patients with TGA presenting beyond the neonatal
period is still considerable. The rapid 2-stage approach remains an interesting alternative for
that population with late referral. Nevertheless, preliminary traditional banding of the
pulmonary trunk may cause the following problems: (1) Imprecision of optimal occlusion may
occur at the time of banding; (2) additional palliative procedures may be necessary to increase
pulmonary blood flow; (3) anatomic distortion of the pulmonary trunk, pulmonary arteries,
or both may occur. (4) The degree of abrupt acute systolic overload on the left ventricle may
impair late ventricular function.
Said that, it sounds like traditional PA banding, used to treat the above-mentioned heart
lesions, is inconvenient in that it does not allow late and fine adjustment according to the
patient’s clinical condition over time, and therefore sometimes requiring new interventions to
achieve that.
2. Historical notes of adjustable PA banding systems
The idea of adjustable banding device composed of a hydraulic cuff and a self-sealing button
was first proposed in 1957. In fact, Jacobson & McAllister proposed a device consisted of a
rubber cuff, with a lateral opening, and connected to a reservoir protected by self-sealing
rubber (Figure 1). It was used on the great vessels of dogs, aiming a congestive heart failure
model. Complications in handling the device were observed.
Figure 1. Jacobson & McAllister proposed in 1957 a device consisted of a rubber cuff, with a lateral opening, and con‐
nected to a reservoir protected by self-sealing rubber
In 1969, Bishop & Cole improved Jacobson & McAllister device by covering the cuff with
silicone, with the aim of reducing local tissue reaction (Figure 2). They induced RV hypertro‐
phy and congestive heart failure in a dog model.
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Figure 2. In 1969, Bishop & Cole device was covered with silicone to reduce tissue reaction
In 1972, Edmunds et al introduced two main changes: an external, non-deformable layer on
the hydraulic cuff and silicone, instead of rubber (Figure 3). However, they observed asym‐
metric inflation or rupture of the cuff, and leakage of the injected material prevented from
clinical use.
Figure 3. In 1972, Edmunds prototype presented an external, non-deformable layer on the hydraulic cuff and silicone,
instead of rubber
In 1985, a new device made of biologically stable material (medical grade silicone) was
introduced by Park et al. (Figure 4) The cuff was covered with reinforced braid and coated
with silicone. The self-sealing button has a silicone diaphragm which did enable repeated
needle puncture, avoiding leaking through the button. The device implanted in dogs and
lambs was easily and effectively adjusted.
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Figure 4. In 1985, Park introduced a prototype made of medical grade silicone. The cuff was covered with reinforced
braid and coated with silicone. The self-sealing button had a silicone diaphragm which did enable repeated needle
puncture.
During that same year, Solis et al. proposed a similar device to the previous one, intended to
prepare the subpulmonary ventricle for the two-stage Jatene operation for the first time in the
literature (Figure 5). Nevertheless, when the system was submitted to a high pressure gradient,
as in the systemic circulation, dilation of the reservoir and the connecting tube occurred. In
addition, there was a tendency of the cuff to bulge laterally under high pressure.
Figure 5. For the first time in the literature, Solis proposed in 1985 a similar device to prepare the subpulmonary ven‐
tricle for the two-stage Jatene operation.
In another study, the same group improved the strength of the material by reinforcing the cuff
and the connecting tube with a spiral of 4-0 silk to withstand systemic arterial pressure. Again,
they experienced bulging of the cuff due to a losing silk.
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3. Adjustable PA banding system for ventricle retraining
We have begun this research line for more than two decades ago, using a balloon catheter to
induce rapid pulmonary ventricular hypertrophy. We developed an experimental model of
young goats, designed to adjust PA banding percutaneously. The main idea is that systolic
overload might be less acute and intense using such a device than a traditional PAB, in which
no changes are possible during ventricular retraining. We have assessed, by means of echo‐
cardiography and cell morphology, the behavior of the right ventricle (RV) submitted to
progressive pressure load imposed by a balloon catheter positioned above the pulmonary
valve. The catheter is a modification of the Swan-Ganz catheter, in which the temperature
probe was removed and the respective port was annulled. The length of the catheter was
shortened so that the distal orifice was placed 30 mm away from the original proximal orifice.
The original balloon was replaced by a manufactured balloon made with segmented polyether
polyurethane copolymer, diluted in N,N-dimethylacetamide (Figure 6).
Figure 6. Balloon catheter prototype, modified from the Swan-Ganz catheter and used for subpulmonary ventricle
retraining.
A rapid RV hypertrophy was achieved in a short period of six to 10 days. It has been demon‐
strated that nonsurgical preparation of the “pulmonary ventricle” for the 2-stage arterial
switch operation could be probably accomplished non-invasively with a balloon catheter
within a very few days.
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In mid-90’s, we started to study experimentally an extravascular adjustable PA banding device,
with a hydraulic cuff system, connected to a self-sealing button for percutaneous systolic
overload adjustment (Figure 7). The banding ring (Hazen Everett Co) is a C-shaped hydraulic
cuff with a 10-mm internal diameter and a 5-mm width. Its outer layer consists of 1-mm-thick
rigid silicone, which keeps it from deforming. The inner surface has a deformable layer of
silicone, which expands, compressing the lumen of the vessel according to the volume injected
into the inflation button. At the 2 ends of the cuff, there are small orifices that are used for
securing the ring to the PA. The extension tube, also made of silicone, links the banding ring
with the insufflation button. It has a 2-mm inner diameter and is 25 cm long. The inflation
button (Bard Access System) is a circular reservoir made of self-sealing silicone, the base of
which includes a metal plate. The reservoir has a port, which is connected to the extension
tube. This button is implanted subcutaneously, thus permitting percutaneous inflation or
deflation of the banding ring.
Figure 7. Adjustable banding device consisting of 3 parts: banding ring (hydraulic cuff), extension tube, and self-seal‐
ing inflation button (reservoir).
The device was implanted on the pulmonary trunk of young goats and inflated so that a 0.7
RV to LV pressure ratio was achieved. Continuous systolic overload was maintained during
a 96-hour period. The study group showed a 74% increase in RV mass when compared with
the control group, while a 66% increase in RV wall thickness was found by serial 2-D echo‐
cardiography. There was a 24% increase in the mean myocyte perimeter, and the myocyte area
increased 61% (Figure 8).
This extravascular device was further compared to the endovascular approach (balloon
catheter), during a 96-hour protocol of continuous systolic overload. Both approaches were
able to induce rapid RV hypertrophy of similar magnitude (Figure 9).
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Figure 9. Both devices are able to induce a similar degree of RV hypertrophy during a 96-hour study period.
4. Intermittent systolic overload
Heart hypertrophy is the main adaptive response of a heart submitted to physiological or
pathological overload. At present, there is great concern about the quality of ventricular
Figure 8. Microphotography of RV cardiac myocytes of animal 6 sectioned transversely at the level of the nucleus, in‐
dicating their perimeters and respective areas: A, baseline samplings; B, samplings after 96 hours of systolic overload.
(Original magnification 400x)
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hypertrophy, leading to questions regarding the most efficient and physiologic training
program and the adaptive mechanisms involved in the process. On the other hand, the
hypertrophy of an athlete’s heart, characterized by normal or increased capillary density with
little or no fibrosis, is a consequence of physiologic stresses like endurance exercise, intermit‐
tent by nature. It is interesting to note that the acquisition of LV mass during physical condi‐
tioning of athletes who practice swimming for example, reaches a peak in about only one week
of training. Then the LV mass remains relatively constant. Based on the fact that both the
cardiac and the skeletal muscles are striated, it has been proposed that a fitness program similar
to that developed by athletes would lead to an acquired muscular mass with better perform‐
ance. Besides that, the knowledge that the myocardium is a postmitotic organ, which means
that cardiomyocytes are capable of proliferating after the neonatal period, leads to the
hypothesis that myocyte hyperplasia may be an important feature in mass acquisition,
although it has not been clarified to what extent it occurs. Trying to improve the rapid
hypertrophic process without causing injury to the myocardium of the subpulmonary
ventricle, we tried to find an analogy between the physiological hypertrophic processes with
intermittent PA banding, where periods of systolic overload were alternated with resting
periods of the subpulmonary ventricle. We formed a hypothesis that submitting the RV to
daytime systolic overload, paired with nighttime resting period, could cause a more beneficial
hypertrophic process, similar to a fitness program of athletes. We then carried out an experi‐
mental study designed to evaluate two protocols of PA banding (continuous and intermittent)
and to analyze histologically the structural phenotype changes (hypertrophy and/or hyper‐
plasia) of the contractile (cardiomyocytes) and noncontractile cells (vascular and interstitial)
from the stimulated ventricle of young goats (Figure 10).
An interesting finding in this study was that both groups presented with significant increase
in the RV free wall thickness. Nevertheless, this increase was significantly greater in the
Intermittent Group (132.1%), compared to a 63.7% increase of in the Continuous Group.
Regarding RV mass, there was a significant increase in the both groups, as compared to the
Control Group (55.6% for the Continuous Group and 88.9% for the Intermittent Group), while
only the Intermittent Group developed a significant increase of septal mass (40%), when
compared to the Control Group (Figure 11). That study has demonstrated that intermittent
systolic overload was more efficient in promoting the increase in RV mass than in the Con‐
tinuous Group, considering the greater septal hypertrophy.
Morphometric analysis revealed that for both stimulated groups, hypertrophy and hyperpla‐
sia of cardiomyocytes occurred (Figure 12). Nevertheless, it is well recognized that interstitial
cell proliferation is also a feature in myocardial hypertrophy caused by other factors. The
interstitium has important functions, such as support for cardiomyocytes, blood and lymphatic
vessels; acting as a defense mechanism against microorganisms; facilitating myocardial
nutrient exchanges; and aiding in cell contraction. However, when interstitium enlargement
is excessive, it may cause early diastolic dysfunction and, in the final stages, also jeopardizes
systolic function. In that study, no significant difference existed in RV collagen area fraction
among the three groups (Continuous, Intermittent, and Control groups). We cannot rule out
the possibility that the observation time (96-hour protocol) was not sufficient to demonstrate
an increase in the interstitial component.
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Lower graph: RV to Pulmonary trunk (PT) gradient (mmHg) of group submitted to continuous RV systolic overload
(*p=0.02).
Figure 10. Diagram of RV systolic overload. Upper graph: RV to Pulmonary trunk (PT) gradient (mmHg) of the group
submitted to 12-hour RV systolic overload paired with 12-hour resting period.
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This hypothesis is corroborated by the studies of Le Bret et al. They have demonstrated in adult
animal model that only two hours per day of RV systolic overload was capable of inducing
Figure 11. Cardiac masses Weight of Control, Continuous and Intermittent Groups. Similar increase in the RV masses
of both stimulated groups was observed, as compared to Control Group (p<0.05). Only Intermittent Group had a sig‐
nificant increase of septal mass (p<0.03), when compared to Control Group. No significant changes were seen in the
LV mass of the three groups (p=0.53).
Figure 12. Histologic aspect of Ki-67-labeled cardiomyocytes. Higher indexes of proliferating cells were found in the
RV of both stimulated groups (Continuous group, 1.13%; Intermittent group, 0.68%) when compared with the corre‐
sponding LV and ventricular septum.
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RV hypertrophy during a period of five weeks. On the other hand, fibrosis was observed only
in animals submitted to traditional PA banding protocol, when compared to intermittent
group. Therefore, it seems that the duration of the training period is important as an inductor
of myocardial fibrosis, responsible for late heart failure.
5. Intermittent systolic overload and heart function
Evaluation of RV function is difficult to image because of its complex morphology. Although
cardiac magnetic resonance imaging is currently considered the reference technique for RV
volumetry and calculation of the ejection fraction, various echocardiographic parameters can
provide reliable information on RV dimensions and RV systolic and diastolic function in daily
clinical practice. Therefore, the myocardial performance index (MPI) has been proposed as a
relatively simple method to assess the combined systolic and diastolic performance of the right
ventricle simultaneously. Focusing on a more sensitive method to detect early disturbances in
ventricular function during the process of rapid RV hypertrophy, we have compared subpul‐
monary ventricular function of intermittent versus continuous systolic overload, using MPI
and a pharmacologic stress technique. The combination of these techniques resulted in greater
sensitivity in assessing ventricular function in that protocol. A new adjustable pulmonary
artery banding system, made by SILIMED Inc. (Rio de Janeiro, Brazil), was implanted just
beyond the pulmonar valve (Figure 13).
Figure 13. The adjustable pulmonary artery banding system, made by SILIMED Inc., Rio de Janeiro. The prototype has
three parts: an insufflating button that includes a self-sealing silicone diaphragm at a top, a banding ring comprising a
hydraulic cuff and an extending tube connecting both hermetically.
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It has been demonstrated that intermittent systolic overload promoted a functionally superior
hypertrophy at rest and under dobutamine stress, and that MPI enhances diagnostic confi‐
dence in ventricular retraining (Figure 14).
Figure 14. Right ventricular myocardial performance index (RVMPI) of sham, continuous, and intermittent groups, un‐
der dobutamine stress. A, Resting condition († p=0.012 compared with that in intermittent group at the same mo‐
ment) and, B, dobutamine stress (* p=0.002 compared with baseline value; † p<0.001 compared with that in
intermittent and sham groups at the same moment).
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Regarding RV end diastolic volume, continuous systolic overload resulted in persistent
dilation throughout the protocol (Figure 15). This could also reflect worse ventricular adap‐
tation in the continuous group. On the other hand, the 12-hour resting periods of intermittent
systolic overload might have optimized subendocardial coronary flow in the intermittent
group, limiting the severity of systolic overload. It would probably provide a better adaptation
and consequent preservation of ventricular function in the intermittent group at periods of
systolic overload.
Figure 15. Right ventricular end diastolic volume changes of Sham, Continuous and Intermittent groups. † p < 0.001
compared with that of the sham group. * p < 0.001 compared with its respective baseline value.
6. Intermittent systolic overload and energetic metabolism
It is essential to understand the molecular mechanisms involved in PAB-induced myocardial
hypertrophy to establish training protocols that lead to a desirable ‘‘physiologic hypertrophy’’
versus a deleterious ‘‘pathologic hypertrophy.’’ Because a known shift occurs in energy
substrate use in favor of glucose in pathologic conditions, energy metabolism might be altered
in PAB ventricular retraining protocols. In addition, recent experimental studies have linked
an unbalanced oxidative and reductive process to a variety of diseases, such as atherosclerosis
and heart failure. Glucose 6-phosphate dehydrogenase (G6PD), the rate limiting enzyme that
commits glucose to the pentose phosphate pathway, is mainly responsible for the generation
of nicotinamide adenine dinucleotide phosphate (NADPH) and ribose 5-phosphate, an
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essential precursor of the de novo synthesis of RNA and DNA. G6PD-derived NADPH, a
cofactor for glutathione and thioredoxin reductase, preserves reducing potentials and protects
the cell from oxidative stress in normal conditions. In human diseases, G6PD can be either
activated or inhibited; however, evidence has emerged that the overexpression and activation
of G6PD enhances NADPH oxidase–derived superoxide generation and increases oxidative
stress in diseases like diabetes, heart failure, and hypertension. In regard to rapid ventricular
training, it is of great interest to evaluate myocardial energy metabolism in response to
different cardiac hypertrophy models and its relationship to heart function. We have compared
the myocardial G6PD activity of young goats in 2 RV training protocols, continuous versus
intermittent systolic overload (Figure 16).
Figure 16. RV/LV ratio of G6PD activity in the sham, continuous, and intermittent groups. *p<0.05 compared with
that in the sham and intermittent groups.
The continuous group presented a series of deleterious effects during rapid subpulmonary
ventricle retraining. Persistent RV dilation was followed by impaired RV function and
increased G6PD activity. Because the pentose phosphate pathway is one of the major sources
of NADPH in cardiac myocytes, this is an important finding, and it may indicate an unbalanced
redox, with the occurrence of oxidative stress and generation of reactive oxygen species related
to NADPH oxidase. The final consequence of this cascade of events would be the cardiomy‐
opathy related to protein aggregation owing to reductive stress. It has been demonstrated that
either G6PD activation or inhibition is associated with diseases. However, growing evidence
has emerged that G6PD overexpression correlates with oxidative and reductive stress, and
new investigational drugs are currently under development to suppress its action. For
instance, diabetic patients had upregulation of G6PD with high NADPH levels, and that was
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linked to inhibition of nitric oxide synthesis and endothelial dysfunction. Although the
mechanisms underlying the increased production of reactive oxygen species in the heart are
not completely understood, it has been proposed that the high rate of glucose oxidation
increases mitochondrial membrane potential, which enhances production of superoxide anion.
The latter would be a modulator in diabetic vasculopathy and precede the development of
diabetic cardiomyopathy. We speculate that, in case of persistent systolic overload, upregu‐
lation and hyperactivity of myocardial G6PD observed in the continuous group strongly
suggest that the pentose phosphate pathway enhances cytosolic NADPH availability, thus
fueling free radical production by NADPH oxidase and uncoupled nitric oxide synthase.
Therefore, it may induce superoxide anion myocardial injury, as well as protein aggregation,
and subsequently heart failure. We postulate that intermittent systolic overload promotes the
desirable effects of myocardial hypertrophy without its adverse effects. We would argue that
the 12-hour resting period allowed the myocardium to replenish energy substrates and
reestablish subendocardial perfusion owing to a lower ventricular wall tension. That would
probably provide better hemodynamic performance at periods of systolic overload.
It is difficult to make definitive conclusions about a hypertrophic process based on a single
enzyme activity. Nevertheless, it is essential to correlate these biochemical findings with
production of superoxide anions and apoptosis to better understand the role of oxidative stress
in hypertrophy training protocols. Previous studies have demonstrated that the oxidative
branch of the pentose phosphate pathway, which produces NADPH and ribulose 5-phosphate,
is essentially irreversible, being controlled primarily by G6PD activity and, hence, the
NADPH/NADP ratio. NADPH oxidase preferentially uses NADPH derived from the pentose
phosphate pathway, and that, in the failing heart, more glucose is oxidized through the pentose
phosphate pathway, with a consequent increase in electron donors available to fuel O2
generating enzymes. Maybe that is the way NADP+ is upregulated. Although this is a non‐
specific pathway of free radical production, we have found a concordance of impaired RV
function of continuous group and increased G6PD. Nevertheless, it would be more objective
if oxygen-derived free radicals or tissue injury markers related to their production had been
measured. Therefore, it is somehow difficult to assume and interpret a whole metabolic
pathway based on the activity of a single enzyme. The hyperactivity in myocardial G6PD,
together with RV dilation and dysfunction, may be related to an unbalanced redox determined
by a constant and pathologic systolic overload. Given that pentose phosphate pathway
enhances cytosolic NADPH availability, this altered energy substrate metabolism can elevate
levels of free radicals by NADPH oxidase, an important mechanism in the pathophysiology
of heart failure. On the other hand, intermittent systolic overload has promoted a more efficient
RV hypertrophy than the continuous one, with better preservation of myocardial performance
and smaller G6PD activity.
7. Mature ventricle retraining
Although the survival of patients with CCTGA is dictated largely by the associated defects,
life expectancy is diminished for patients even with the isolated form of the condition. A
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number of studies have confirmed that life expectancy is substantially diminished even for
patients who have reached adulthood. The most common cause of death is congestive heart
failure secondary to morphologically right (systemic) ventricular dysfunction, often associated
with regurgitation of the tricuspid valve. The traditional surgical approach to the treatment of
patients with CCTGA maintains the morphologically RV and tricuspid valve in the systemic
circulation. However, dysfunction of the systemic (morphologically right) ventricle or
systemic atrioventricular (tricuspid) valve tends to develop and worsen with time, which may
lead to significant morbidity and mortality. Tricuspid regurgitation can be addressed by
valvuloplasty or replacement of the systemic atrioventricular valve. Nevertheless, this
procedure is often unsuccessful in preventing or reversing right ventricular dysfunction. There
are indeed anatomical and physiological considerations that support the assumption that the
LV is more suitable than the right to serve the systemic circulation. First of all, LV (with its
cylindrical shape, its concentric contraction pattern, and both the inlet and outlet orifices
situated in close proximity) seems ideally adapted to work as a pressure pump, whereas the
RV (with its crescent-shaped cavity, its large internal surface area-to-volume ratio, its bellows-
like contraction pattern, and its more separated inlet and outlet segments) seems better suited
to serve as a low-pressure volume pump chamber. Also, the LV has two coronary arteries (left
anterior descending and circumflex), while the RV has only one (right coronary). Furthermore,
the papillary muscles of the RV are small and numerous, originating both from the septum
and from the right ventricular free wall, in contrast to the two papillary muscles of the LV.
This architecture allows the tricuspid valve to be pulled apart as the RV dilates, leading to
tricuspid regurgitation. In long-term, patients with CCTGA begins to dilate RV and the
tricuspid annulus (which is the systemic valve), allowing RV blood regurgitation during
ventricular contraction and, consequently, pulmonary congestion and dyspnea. The high late
mortality associated with the traditional approach has stimulated a number of groups to
propose a more anatomic repair on the basis of the hypothesis that establishment of atrioven‐
tricular and ventriculoarterial concordance would improve the long term survival of patients
with this anomaly. This approach has been named as double switch operation, i.e., atrial level
circulation switch by the Senning procedure and arterial switch operation at the same time.
This strategy has the appealing theoretic advantage of recruiting the morphologically LV and
mitral valve to sustain systemic pressure and resistance, thus relieving the hemodynamic
burden on the RV and tricuspid valve. Many of these patients are older and are seen because
of right ventricular failure, usually with tricuspid valve regurgitation and often without
associated defects. As would be expected in these cases, the LV is physiologically unprepared
to sustain systemic pressure and resistance, because it has been working as the pulmonary
ventricle. Therefore, double switch procedure must be performed after a preliminary PA
banding procedure to recondition the LV. Although PAB appears to be capable of providing
adequate LV training when done at an early age, it is not always suitable for mature myocar‐
dium, with disappointing results in older patients. Because of the high degree of variability
among these patients, optimal band tightness is not always achieved on the first effort and is
often limited by the onset of LV dysfunction. The retraining process of the LV, especially in
older patients, may take months before obtaining the necessary LV hypertrophy to sustain
systemic pressure and vascular resistance. According to Mavroudis and Backer, in patients
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with TGA and failed atrial inversion, aged from 1.9 to 23 years, it took an average of 15.6 months
to retrain the subpulmonary ventricle for the two-stage Jatene operation. In addition, it has
been described in the literature the need for subsequent reoperations to readjust PA banding
in cases where patient cannot achieve adequate LV hypertrophy. The difficulties in retraining
adult myocardium with the traditional approach has stimulated several groups to propose a
more physiologic protocol based on the hypothesis that intermittent systolic overload would
improve the quality of subpulmonary ventricle hypertrophy. Such an approach has the
appealing advantage of ventricular retraining with no collagen formation, providing a more
physiologic hypertrophy. However, the time necessary to retrain these ventricles and the best
way to achieve a more physiologic hypertrophy and assess the specific histologic changes
involved in this process are still required. We have compared the histomorphometric changes
of PAB-induced RV hypertrophy of adult goats, with the emphasis on a detailed analysis of
the myocardium adaptation process (Table 1).
Sham
N = 6
Traditional
N = 6
Intermmitent
N = 6
p value
Mass (g/kg) 0.79 ± 0.15 1.08 ± 0.17 * 1,24 ± 0.16 † <0.05
Water Content (%) 79.16 ± 1.28 79.67 ± 1.25 80.61 ± 1.87 0.27
Cardiomyocyte diameter (µm) 11.54 ± 0.89 12.96 ± 1.35 13.76 ± 1.68 † <0.05
Nuclei diameter (µm) 3.86 ± 0.14 4.40 ± 0.48 4.74 ± 0.71 † <0.05
Collagen percentage area (%) 2.94 ± 0.65 5.82 ± 1.91 * 3.44 ± 1.24 # <0.05
Cardiomyocyte Ki67+ cells (cells/
field)
0.33 (0.08-0.75) 0.33 (0.08-0.83) 0.25 (0.08-0.58) 0.89
Interstitial/Vessel Ki67+ cells
(cells/field)
2.67 (1.00-3.58) 2.83 (1.25-8.50) 2.17 (1.75-4.75) 0.68
Values: means ± SD or medians (limits)
* p<0.05 compared Traditional and Sham groups;
† p<0.05 compared Intermittent and Sham groups;
# p<0.05 compared Intermittent and Traditional groups.
Table 1. Gross and histomorphometric RV findings in Sham, Traditional and Intermittent groups
The prototype used in this study (SILIMED, Rio de Janeiro, Brazil) represents the adult version
of the small adjustable PAB system used previously in young animals (Figure 17). Its dimen‐
sions were planned to support higher pressure gradients in adolescents and adults patients
considered for subpulmonary ventricle retraining. All parts of the Adjustable Banding System
are made of biologically stable material (medical grade silicone).
The banding ring is a C-shaped hydraulic cuff that has three layers. The inner wall of the
banding ring is formed by a very thin and flexible silicone that allows centripetal distension.
Differently from the young animal prototype, the outer layer is divided in two parts, both
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consisting of 1.0-mm-thick rigid silicone each, reinforced with a polyester mesh. The outer
external layer presents some small holes along the non apart borders, which are used for
securing it firmly with sutures to the adventitia of the artery. This keeps the adjustable banding
system from migrating distally and impinging on the pulmonary artery bifurcation. The
external layer prolongs with two apart ends, planned for further adjustment of the hydraulic
cuff, when placed around the artery, by suturing together the ends. The inner external layer
prolongs alongside the cuff as a canoe, to keep it from deforming. The connecting tubing has
1.0 mm inner diameter. The inflation reservoir used to pump fluid to the hydraulic cuff consists
of a ceramic cylindrical reservoir, with a self-sealing silicone diaphragm at the top, which keeps
the banding system leak proof after repeated needle puncture of the reservoir.
The two regimens of ventricular training, traditional and intermittent, have promoted different
degrees of myocardial hypertrophy. However, it was less intense and longer in adult animals
than that observed previously in young goat hearts. Histomorphometric and echocardio‐
graphic data indicated that intermittent RV systolic overload promoted a harmless RV
hypertrophy in adult goats during a 4-week study period. On one hand, the primary mecha‐
nism of RV mass acquisition was probably related to increased protein synthesis and cell
hypertrophy rather than myocardial hyperplasia or edema. On the other hand, the traditional
PAB group evolved with greater collagen production, which is one of the important mecha‐
nisms of late ventricular failure. The absence of myocardial edema and significant cell
proliferation observed in that study suggests that the mass acquisition was probably related
to enhanced protein synthesis, both intracellular (contractile proteins) and extracellular
(matrix proteins). In the adult heart of mammals, it is generally believed that almost none of
the cardiomyocytes proliferate and that the hypertrophy process functions as the fundamental
adaptive response. The magnitude of cardiomyocyte hypertrophy then depends on the age at
which the stimulus is produced. As predicted in an adult model, no significant cellular
proliferation was observed in any cardiac segment, contrary to the findings of similar experi‐
mental studies in young animals, in which RV responds not only with hypertrophy of the
myocardial fibers but also with hyperplasia of the contractile and interstitial myocardial cells.
Figure 17. The adult banding device consists of an inflatable C-shaped hydraulic cuff (24-mm diameter) and an infla‐
tion reservoir connected hermetically to each other by a 2.0-mm diameter tube (SILIMED, Rio de Janeiro, Brazil).
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Although the intermittent group was the one least exposed to systolic overload, a more efficient
RV hypertrophy was observed, just as documented previously by our studies in young goat
hearts. Similarly, the hemodynamic results showed that the intermittent group could achieve
greater RV-to-PA pressure gradients than the traditional group during the 4-week study
period. Intermittent systolic overload mimics exercise training, which can benefit the trained
myocardium with improved subendocardial perfusion. On one hand, it is likely that the
mechanism of this hypertrophic process may be developed during the resting periods with
ideal oxygen transport and, hence, without the collagen deposition resulting from continuous
Figure 18. Photomicrographies of the right ventricular myocardium from four representative animals, two from the
Traditional (A and B) and two from the Intermittent (C and D) group, after four weeks of systolic overload. Panels A
and B show a higher density and intensity of collagen staining (red fibers around individual cardiomyocytes- endomy‐
sial fibrosis) than that in panels C and D. Sirius-red staining, objective magnification-20X.
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relative diastolic hypoperfusion. On the other hand, the traditional group had deleterious
effects at the end of the protocol, with more collagen deposition in the RV interstitium. The
mean RV collagen area fraction of the Traditional group was significantly greater than in the
Sham group (98% increase; p<0.01), and greater than that in the Intermittent group (69.2%
increase; p<0.05). The histological distribution of collagen in representative animals from
trained groups is demonstrated in Figure 18. This collagen deposit may be the key determinant
of the impaired RV function previously observed on the same protocol. Accordingly, Le Bret
and colleagues reported myocardial fibrosis associated with continuous overload and no
fibrosis in their “fitness” group, during a 5-week period in adult sheep. Although the results
with adjustable intermittent PAB are encouraging, it is premature to assume this as the
definitive solution for adult myocardium retraining.
8. Adjustable PA banding and hypoplastic left heart syndrome
More recently, bilateral PA banding has been applied to hypoplastic left heart syndrome
(HLHS). The mitral and aortic valves present either with atresia or hypoplasia. This results in
a situation where the left side of the heart is completely unable to support systemic circulation,
though the right side of the heart is typically normally developed. Blood returning from the
lungs to the LA must pass through an atrial septal defect to the right side of the heart. The RV
must then pump blood both to the lungs (via the pulmonary trunk) and out to the body (via
a patent ductus arteriosus). The patent Ductus Arteriosus, a normal structure in the fetus, is
often the only pathway through which blood can reach the body from the heart. When the
Ductus Arteriosus begins to close, as it typically does in the first days of life, the blood flow to
the body will severely diminish, resulting in dangerously low blood flow to vital organs and
leading to shock. Without treatment, HLHS is uniformly fatal, often within the first hours or
days of life. The most commonly pursued treatment for HLHS is "staged reconstruction" in
which a series of operations, usually three, are performed to reconfigure the child's cardio‐
vascular system to be as efficient as possible, despite the lack of an adequate LV. The first
operation in the staged approach is the Norwood operation and is typically performed in the
first week of life. With the Norwood operation, the RV becomes the systemic or main ventricle
pumping to the body, and a systemic-to-pulmonary shunt aims redirectioning circulatory
pathways to protect the pulmonary vasculature from excessive blood flow and optimize
systemic organ flows. However, some overloading of the systemic right ventricle still persists
after this operation. Also, such major surgical procedure is usually performed in the neonatal
period (sometimes in a low-birth weight patient and unfavorable anatomy), which may result
in sub-optimal neurological outcomes in the long-term. Because of the extensive reconstruction
of the aorta that must be done, this operation is one of the most challenging heart surgeries in
Pediatrics. This traditional surgical approach of newborns with HLHS is complex and
continues to have significant mortality compared with other neonatal cardiac operations.
An alternative approach for palliation of hypoplastic left heart in the neonatal period has been
stenting the arterial duct in combination with branch PA banding and atrial septostomy, as
needed. The so called hybrid stage I palliation has been considered the preferred therapeutic
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approach in high-risk neonates. However, fine adjustments of the amount of pulmonary blood
flow, which is a critical issue, has proved to be a particularly difficult aspect of the procedure.
This can be readily explained when it is recalled that Poiseuille’s law predicts that blood flow
is related to the fourth power of the radius of the vessel. Therefore, a minor alteration in
diameter will have a large impact on flow and pressure gradient across the band site. Generally,
the bands are surgically adjusted (tighten or loosened), based on pressure measurements and
the arterial oxygen saturation monitoring. A systolic pressure in the distal pulmonary artery
less than half of the systemic pressure and an arterial oxygen saturation of 75%-85% usually
reflect an adequate balance between the pulmonary and systemic blood flow. This may be
readily achieved in the operating room, with an open chest and under artificial conditions.
However, in the postoperative period, which may be quite unpredictable, the fixed pulmonary
bandings do not allow for fine adjustments according to the underlying clinical needs of the
patient. Moreover, in order to avoid hypoxemia as the infant rapidly grows up, the balance
between the pulmonary and systemic blood flows should be adjusted, which is impossible
with the fixed bands. To deal with these problems, we devised a mini banding device that
allows for fine percutaneous adjustments of the pulmonary blood flow in the neonate (Figure
19). The banding ring is a C-shaped hydraulic cuff, with 5 mm width, and a rigid outer layer,
reinforced with a polyester mesh, which keep it from deforming centrifugally. It can be used
in pulmonary arteries varying from 3 mm to 6 mm internal diameter range.
Figure 19. The adjustable pulmonary artery banding system (SILIMED, Rio de Janeiro, Brazil) used for Hybrid Stage I
palliation for HLHS.
This innovative percutaneous mini adjustable banding system permits a fine control of the
pulmonary blood flow by increasing or decreasing accurately the cross-sectional diameter of
the pulmonary arteries. Therefore, it is adjusted according to the underlying clinical conditions
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of the patients: hypoxemia is, for instance, managed by unfastening the pulmonary artery
banding circumference. Once the adjustable banding ring is placed around the PA’s and the
inflation reservoirs left in the infraclavicular subcutaneous tissue, the degree of banding rings
constriction is adjusted after sternal closure (Figure 20). Each band is inflated with saline
solution to decrease arterial oxygen saturation to the 75%-85% range, while breathing under
a 30% inspired oxygen fraction.
Figure 20. Inflating reservoirs positioned in the infraclavicular area (arrows), one for each pulmonary artery for inde‐
pendent percutaneous blood flow adjustment.
We have performed Hybrid Stage I palliation for HLHS using the adjustable PA band (APAB
group) in 3 patients (1.8 kg - 2.8 kg) and traditional bands (TPAB group) in 3 patients (2.0 kg
- 3.3 kg). The babies were followed closely with serial echocardiographic assessment every
week. During inter-stage 1-2, several additional percutaneous adjustments of the PA’s banding
systems were necessary to maintain the arterial oxygen saturation in the recommended range
according to somatic growth. Figure 21 shows the O2 saturation behavior of both groups during
interstage 1-2 period.
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Figure 21. Traditional PA banding group evolved with progressive decrease of oxygen saturation during interstage
1-2, while the group using adjustable PA bands maintained more stable arterial oxygen saturation according to so‐
matic growth.
In the APAB group, all patients reached stage 2 operation, and one of them has already
completed Fontan circulation at 2 years of age, while in the TPAB group, two cases underwent
the stage 2 operation and one patient died just before stage 2 operation (pulmonary infection).
This small series of HLHS cases demonstrated that customization of the pulmonary blood flow
seemed to result in a more precise balance between the pulmonary and systemic circulations
during the interstage 1-2 period. The use of adjustable PA bands in the stage-1 hybrid proce‐
dure for HLHS can provide a more stable clinical condition, according to the rapid somatic
growth and underlying clinical needs of the patient. However, the calibration of the banding
cuffs was sometimes difficult to achieve, due to the extreme complexity of the continuously
changing relationship between systemic and pulmonary vascular resistance, with the depend‐
ency upon several inter-related variable such as the values of the arterial pO2, pCO2, pH,
hemoglobin, cardiac output, level of sedation, use of peripheral and/or pulmonary vasodila‐
tors, etc. Nevertheless, fine and reversible adjustments could be performed as many times as
needed, both in acute and ambulatory settings, avoiding further surgical interventions. The
use of this innovative banding system seemed to result in a more predictable postoperative
course, and in a more stable patient, which is highly desirable for the comprehensive phase II
operation. A concern with any PAB technique or device, including ours, is the possibility of
causing vessel distortions or stenoses, which may have a deleterious impact for subsequent
cavo-pulmonary operations. Fortunately, the scar tissue surrounding the banding devices was
minimal in our patient and did not result in any of these complications. The cases electively
submitted to the “comprehensive” stage II surgical palliation showed the anatomy of the
pulmonary arteries well preserved with no distortions.
In summary, the use of our innovative mini PAB system allowed for a fine control of the
pulmonary blood flow in neonates with HLHS undergoing phase I palliation. This customi‐
zation of the pulmonary blood flow according to the underlying clinical needs of an infant
with rapid somatic growth seemed to result in a more precise balance between the pulmonary
and systemic circulations during the inter-stage period.
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